Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 35.40 INR
Change Today -0.50 / -1.39%
Volume 1.2K
PRNX On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

parnax lab ltd (PRNX) Snapshot

Open
35.00
Previous Close
35.90
Day High
36.45
Day Low
35.00
52 Week High
06/9/14 - 61.00
52 Week Low
01/19/15 - 25.10
Market Cap
301.1M
Average Volume 10 Days
38.8K
EPS TTM
-3.29
Shares Outstanding
8.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PARNAX LAB LTD (PRNX)

Related News

No related news articles were found.

parnax lab ltd (PRNX) Related Businessweek News

No Related Businessweek News Found

parnax lab ltd (PRNX) Details

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India. It offers liquid orals, ointments, and external powders. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. Parnax Lab Limited was incorporated in 1982 and is based in Mumbai, India.

Founded in 1982

parnax lab ltd (PRNX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

parnax lab ltd (PRNX) Key Developments

Parnax Lab Ltd Approves Executive Appointments

Parnax Lab Ltd. announced that the Board of Directors of the company at its meeting held on March 31, 2015, approved the appointment of Mrs. Mihir Shah as women director of the company and Mr. T. V. Anantharaman as an Independent director of the company.

Parnax Lab Limited, Board Meeting, Mar 31, 2015

Parnax Lab Limited, Board Meeting, Mar 31, 2015. Agenda: To appoint independent women director / women director in the company.

Parnax Lab Limited Announces Unaudited Consolidated and Standalone Earnings Results for the Third Quarter and First Nine Months Ended December 31, 2014

Parnax Lab Limited announced unaudited consolidated and standalone earnings results for the third quarter and first nine months ended December 31, 2014. For the quarter, on standalone basis, the company announced net sales or income from operations, net of excise duty of INR 47.876 million compared to INR 44.719 million a year ago. Loss from operations before other income, finance costs and exceptional items were INR 0.724 million compared to INR 0.232 million a year ago. Loss from ordinary activities before tax was INR 3.228 million compared to INR 3.117 million a year ago. Net loss was INR 3.828 million or INR 0.45 per basic and diluted share for before and after extraordinary items compared to INR 3.117 million or INR 0.37 per basic and diluted share for before and after extraordinary items a year ago. For the first nine months, on standalone basis, the company announced net sales or income from operations, net of excise duty of INR 119.777 million compared to INR 133.871 million a year ago. Loss from operations before other income, finance costs and exceptional items were INR 5.655 million compared to INR 0.168 million a year ago. Loss from ordinary activities before tax was INR 16.080 million compared to INR 9.353 million a year ago. Net loss was INR 16.080 million or INR 1.89 per basic and diluted share for before and after extraordinary items compared to INR 9.353 million or INR 1.10 per basic and diluted share for before and after extraordinary items a year ago. For the quarter, on consolidated basis, the company announced net sales or income from operations, net of excise duty of INR 286.574 million compared to INR 183.560 million a year ago. Profit from operations before other income, finance costs and exceptional items were INR 28.016 million compared to INR 16.130 million a year ago. Profit from ordinary activities before tax was INR 16.670 million compared to INR 7.425 million a year ago. Net profit was INR 16.670 million or INR 1.96 per basic and diluted share for before and after extraordinary items compared to INR 7.425 million or INR 0.87 per basic and diluted share for before and after extraordinary items a year ago. For the first nine months, on consolidated basis, the company announced net sales or income from operations, net of excise duty of INR 767.648 million compared to INR 469.066 million a year ago. Loss from operations before other income, finance costs and exceptional items were INR 75.908 million compared to INR 60.336 million a year ago. Loss from ordinary activities before tax was INR 43.443 million compared to INR 34.816 million a year ago. Net profit was INR 43.443 million or INR 5.09 per basic and diluted share for before and after extraordinary items compared to INR 34.816 million or INR 4.08 per basic and diluted share for before and after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRNX:IN 35.40 INR -0.50

PRNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRNX.
View Industry Companies
 

Industry Analysis

PRNX

Industry Average

Valuation PRNX Industry Range
Price/Earnings 9.3x
Price/Sales 0.3x
Price/Book 1.3x
Price/Cash Flow 5.3x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PARNAX LAB LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.